Odette Viñas

1.7k total citations
57 papers, 1.3k citations indexed

About

Odette Viñas is a scholar working on Rheumatology, Immunology and Epidemiology. According to data from OpenAlex, Odette Viñas has authored 57 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Rheumatology, 15 papers in Immunology and 12 papers in Epidemiology. Recurrent topics in Odette Viñas's work include Systemic Lupus Erythematosus Research (15 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Liver Disease Diagnosis and Treatment (10 papers). Odette Viñas is often cited by papers focused on Systemic Lupus Erythematosus Research (15 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Liver Disease Diagnosis and Treatment (10 papers). Odette Viñas collaborates with scholars based in Spain, United States and Netherlands. Odette Viñas's co-authors include Guadalupe Ercilla, Jordi Vives, Albert Parés, Teresa Gallart, Raimón Sanmartí, Juan D. Cañete, J Rodés, Jordi Vilà, Anna Merino and Pilar Arrizabalaga and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and The Journal of Immunology.

In The Last Decade

Odette Viñas

55 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Odette Viñas Spain 21 395 337 318 318 180 57 1.3k
Rubén D. Mantilla Colombia 25 90 0.2× 211 0.6× 716 2.3× 435 1.4× 171 0.9× 46 1.9k
Elena Generali Italy 18 90 0.2× 176 0.5× 339 1.1× 229 0.7× 81 0.5× 40 904
Mark F. Gourley United States 22 245 0.6× 317 0.9× 1.4k 4.3× 1.1k 3.5× 68 0.4× 35 2.4k
John Verrier Jones Canada 20 61 0.2× 166 0.5× 583 1.8× 507 1.6× 103 0.6× 47 1.3k
Daniel B. Magilavy United States 19 62 0.2× 110 0.3× 443 1.4× 513 1.6× 177 1.0× 37 1.4k
F.J. Paradinas United Kingdom 31 218 0.6× 275 0.8× 117 0.4× 82 0.3× 435 2.4× 67 2.7k
T Egeland Norway 24 156 0.4× 117 0.3× 225 0.7× 574 1.8× 247 1.4× 53 1.8k
Benedicte A. Lie Norway 22 104 0.3× 266 0.8× 205 0.6× 571 1.8× 269 1.5× 35 1.4k
Myoung Hee Park South Korea 21 49 0.1× 181 0.5× 157 0.5× 452 1.4× 131 0.7× 83 1.2k
Seymour Fein United States 17 113 0.3× 207 0.6× 58 0.2× 233 0.7× 271 1.5× 40 1.0k

Countries citing papers authored by Odette Viñas

Since Specialization
Citations

This map shows the geographic impact of Odette Viñas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Odette Viñas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Odette Viñas more than expected).

Fields of papers citing papers by Odette Viñas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Odette Viñas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Odette Viñas. The network helps show where Odette Viñas may publish in the future.

Co-authorship network of co-authors of Odette Viñas

This figure shows the co-authorship network connecting the top 25 collaborators of Odette Viñas. A scholar is included among the top collaborators of Odette Viñas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Odette Viñas. Odette Viñas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xipell, Marc, Gema M. Lledó, Ricard Cervera, et al.. (2023). Anti-dsDNA B-Cell ELISpot as a Monitoring and Flare Prediction Tool in SLE Patients. Journal of Clinical Medicine. 12(4). 1295–1295. 3 indexed citations
4.
Barilaro, Giuseppe, Carlo Della Rocca, Estíbaliz Ruiz‐Ortiz, et al.. (2022). Predictive value of the adjusted Global Anti-Phospholipid Syndrome Score on clinical recurrence in APS patients: a longitudinal study. Lara D. Veeken. 62(4). 1576–1585. 7 indexed citations
5.
Gratacós‐Ginès, Jordi, Oswaldo Ortíz, Sergio Rodríguez‐Tajes, et al.. (2019). Higher seroprevalence of hepatitis E virus in autoimmune hepatitis: Role of false‐positive antibodies. Liver International. 40(3). 558–564. 11 indexed citations
6.
Moroni, Luca, et al.. (2019). Economic Analysis of the Use of Anti-DFS70 Antibody Test in Patients with Undifferentiated Systemic Autoimmune Disease Symptoms. The Journal of Rheumatology. 47(8). 1275–1284. 8 indexed citations
8.
Retamozo, Soledad, Miriam Akasbi, Pilar Brito‐Zerón, et al.. (2013). Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.. PubMed. 30(5). 686–92. 37 indexed citations
9.
Haro, Isabel, María J. Gómara, Maria Perez, et al.. (2011). Antibodies against β-fibrin synthetic peptides: A study of their association with the immunogenetic background and disease course of rheumatoid arthritis patients. European Journal of Medicinal Chemistry. 46(4). 1095–1102. 3 indexed citations
10.
Sanmartí, Raimón, Eduard Graell, Maria Perez, et al.. (2009). Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis. Arthritis Research & Therapy. 11(5). R135–R135. 40 indexed citations
11.
Sanmartí, Raimón, Guadalupe Ercilla, M. Larrosa, et al.. (2006). Prognostic factors of radiographic progression in early rheumatoid arthritis: a two year prospective study after a structured therapeutic strategy using DMARDs and very low doses of glucocorticoids. Clinical Rheumatology. 26(7). 1111–1118. 41 indexed citations
12.
Perez, Maria, María J. Gómara, Ana M. Fernández‐Alonso, et al.. (2006). Synthesis of Overlapping Fibrin Citrullinated Peptides and their use for Diagnosing Rheumatoid Arthritis. Chemical Biology & Drug Design. 68(4). 194–200. 8 indexed citations
13.
Amézaga, Núria, Marta Crespo, Mónica Millán, et al.. (2006). Relevance of MICA antibodies in acute humoral rejection in renal transplant patients. Transplant Immunology. 17(1). 39–42. 11 indexed citations
14.
Ramos‐Casals, Manuel, Albert Parés, Luis J. Jara, et al.. (2005). Antimitochondrial antibodies in patients with chronic hepatitis C virus infection: description of 18 cases and review of the literature. Journal of Viral Hepatitis. 12(6). 648–654. 24 indexed citations
15.
Morer, Ástrid, Odette Viñas, Luisa Lázaro, et al.. (2005). D8/17 Monoclonal Antibody: An Unclear Neuropsychiatric Marker. Behavioural Neurology. 16(1). 1–8. 20 indexed citations
16.
Morer, Ástrid, Odette Viñas, Luisa Lázaro, et al.. (2005). Subtyping obsessive-compulsive disorder: Clinical and immunological findings in child and adult onset. Journal of Psychiatric Research. 40(3). 207–213. 24 indexed citations
17.
Parés, Albert, et al.. (1997). Antibodies to mycobacterial 65‐kD heat shock protein cross‐react with the main mitochondrial antigens in patients with primary biliary cirrhosis. European Journal of Clinical Investigation. 27(8). 667–672. 46 indexed citations
18.
Pino-Otín, María Rosa, Manel Juan, Miguel Á. de la Fuente, et al.. (1995). CD50 (intercellular adhesion molecule‐3) is expressed at higher levels on memory than on naive human T cells but induces a similar calcium mobilization on both subsets. Tissue Antigens. 46(1). 32–44. 16 indexed citations
19.
Juan, Manel, Odette Viñas, María Rosa Pino-Otín, et al.. (1994). CD50 (intercellular adhesion molecule 3) stimulation induces calcium mobilization and tyrosine phosphorylation through p59fyn and p56lck in Jurkat T cell line.. The Journal of Experimental Medicine. 179(6). 1747–1756. 59 indexed citations
20.
Plana, Montserrat, Odette Viñas, Oscar De La Calle-Martin, et al.. (1991). Induction of interleukin 2 (IL2) and interferon‐γ and enhancement of IL2 receptor expression by a CD26 monoclonal antibody. European Journal of Immunology. 21(4). 1085–1088. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026